| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.11. | Mike Doyle wird neuer Non-Executive Chairman bei AirSculpt Technologies | 1 | Investing.com Deutsch | ||
| 17.11. | AirSculpt Technologies names Mike Doyle as non-executive chairman | 1 | Investing.com | ||
| 17.11. | Airsculpt Technologies, Inc.: AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board | 188 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 07.11. | AirSculpt outlines $153M 2025 revenue outlook as company targets GLP-1-driven growth and margin improvement | 1 | Seeking Alpha | ||
| 07.11. | AirSculpt Technologies Shares Drop 43% After Q3 Revenue Decline, Guidance Cut | - | RTTNews | ||
| AIRSCULPT TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 07.11. | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | AirSculpt Technologies verfehlt Q3-Prognosen deutlich - Aktie bricht ein | 1 | Investing.com Deutsch | ||
| 07.11. | AirSculpt Technologies GAAP EPS of -$0.15 misses by $0.12, revenue of $35M misses by $4.8M | 1 | Seeking Alpha | ||
| 07.11. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Third Quarter Fiscal 2025 Results | 455 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 06.11. | A Look at AirSculpt Technologies' Upcoming Earnings Report | 1 | Benzinga.com | ||
| 05.11. | AirSculpt Technologies: Executive Chairman Aaron Rollins legt Ämter nieder | 1 | Investing.com Deutsch | ||
| 05.11. | Airsculpt Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.08. | AirSculpt Technologies: Leiter des Rechnungswesens tritt zurück | 1 | Investing.com Deutsch | ||
| 01.08. | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 01.08. | AirSculpt reiterates $160M-$170M 2025 revenue outlook amid record lead growth and cost savings | 2 | Seeking Alpha | ||
| 01.08. | Airsculpt Technologies: EPS verfehlt Schätzungen um 0,02 $ - Umsatz schlechter als erwartet | 4 | Investing.com Deutsch | ||
| 01.08. | AirSculpt Technologies GAAP EPS of -$0.01, revenue of $44M | 2 | Seeking Alpha | ||
| 01.08. | Airsculpt Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.08. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results | 1 | GlobeNewswire (USA) | ||
| 31.07. | Examining the Future: AirSculpt Technologies' Earnings Outlook | 1 | Benzinga.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS | 8,060 | +91,45 % | INBS partners with Syrma Johari to boost production, improve margins | ||
| SIEMENS HEALTHINEERS | 44,920 | +0,54 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,760 | +0,37 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,980 | +0,60 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,000 | -1,57 % | EILMELDUNG: Carl Zeiss Meditec-Aktie tritt auf der Stelle - Anleger warten auf das nächste Signal. | ||
| ALIGNMENT HEALTHCARE | 19,770 | +2,75 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| EKSO BIONICS | 8,930 | -15,60 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| GERRESHEIMER | 27,580 | 0,00 % | Comeback 2026! Verzehnfachung möglich? Evotec, Gerresheimer, Desert Gold Aktie! | Auf der Suche nach einem möglichen Verzehnfacher im Gold-Sektor? Dies halten Analysten bei Desert Gold für möglich. Die jüngste PEA für das Flaggschiff-Gold-Projekt löst neue Kursfantasie aus. Damit... ► Artikel lesen | |
| CERIBELL | 21,500 | -0,97 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| UNITEDHEALTH | 280,10 | -0,04 % | ROUNDUP/Aktien New York: Kaum verändert am vorletzten Handelstag des Jahres | NEW YORK (dpa-AFX) - Bei den wichtigsten US-Aktienindizes hat sich am Dienstag am vorletzten Handelstag des Jahres wenig getan. Der Dow Jones Industrial sank im frühen Handel um 0,08 Prozent auf 48.423... ► Artikel lesen | |
| HEARTFLOW | 29,740 | -1,56 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,220 | -0,97 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OTTOBOCK | 65,25 | 0,00 % | IPO-Rückblick 2025: TKMS, Klarna, Ottobock und Circle im Anleger-Check | Guten Tag, liebe Leserinnen und Leser,
2025 war ein vergleichsweise starkes Jahr für Neuemissionen. Allein in der ersten Jahreshälfte wagten weltweit 539 Unternehmen den Schritt an die Börse und sammelten... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,550 | -0,29 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,180 | -2,73 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen |